O Shaughnessy Asset Management LLC grew its stake in shares of Owens & Minor, Inc. (NYSE:OMI) by 10.8% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 18,336 shares of the company’s stock after acquiring an additional 1,783 shares during the period. O Shaughnessy Asset Management LLC’s holdings in Owens & Minor were worth $776,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of the company. Harvest Fund Management Co. Ltd acquired a new stake in shares of Owens & Minor during the 1st quarter valued at about $31,000. Ameritas Investment Company LLC bought a new position in Owens & Minor during the first quarter valued at approximately $32,000. First Trust Advisors LP bought a new position in Owens & Minor during the first quarter valued at approximately $56,000. Human Investing LLC acquired a new stake in Owens & Minor in the first quarter valued at approximately $69,000. Finally, Islay Capital Management LLC acquired a new position in shares of Owens & Minor during the 1st quarter worth $131,000. Institutional investors and hedge funds own 91.35% of the company’s stock.
OMI stock opened at $36.25 on Wednesday. The business’s 50-day moving average price is $40.72 and its two-hundred day moving average price is $39.13. The company has a current ratio of 1.67, a quick ratio of 0.61 and a debt-to-equity ratio of 1.19. The firm has a market cap of $2.74 billion, a PE ratio of 10.89, a P/E/G ratio of 0.48 and a beta of 0.20. Owens & Minor, Inc. has a 1-year low of $13.74 and a 1-year high of $49.16.
The business also recently announced a quarterly dividend, which will be paid on Thursday, September 30th. Shareholders of record on Wednesday, September 15th will be issued a dividend of $0.002 per share. The ex-dividend date is Tuesday, September 14th. This represents a $0.01 annualized dividend and a yield of 0.02%. Owens & Minor’s dividend payout ratio (DPR) is currently 0.44%.
In other news, Director Robert J. Henkel purchased 1,000 shares of Owens & Minor stock in a transaction on Monday, September 13th. The stock was purchased at an average price of $35.00 per share, with a total value of $35,000.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Michael Wayne Lowry sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 10th. The stock was sold at an average price of $38.63, for a total value of $193,150.00. The disclosure for this sale can be found here. Insiders have sold a total of 133,482 shares of company stock worth $5,128,885 over the last 90 days. Corporate insiders own 4.65% of the company’s stock.
OMI has been the topic of a number of analyst reports. Credit Suisse Group lowered their price objective on Owens & Minor from $43.00 to $42.00 and set a “neutral” rating on the stock in a report on Wednesday, August 4th. boosted their target price on Owens & Minor from $39.00 to $46.00 and gave the stock a “neutral” rating in a report on Thursday, May 27th. Zacks Investment Research lowered Owens & Minor from a “buy” rating to a “sell” rating in a report on Friday, August 6th. Robert W. Baird lifted their target price on shares of Owens & Minor from $52.00 to $55.00 and gave the stock an “outperform” rating in a report on Thursday, May 27th. Finally, TheStreet raised Owens & Minor from a “c+” rating to a “b-” rating in a report on Monday, August 23rd. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Owens & Minor currently has an average rating of “Hold” and an average target price of $40.22.
Owens & Minor Profile
Owens & Minor, Inc engages in the provision of healthcare solutions. It operates through the Global Solutions and Global Products segments. The Global Solutions segment comprises of United States distribution, outsourced logistics, and value-added services business. The Global Products segment manufactures and sources medical surgical products through the production and kitting operations.
See Also: What is the operating income formula?
Want to see what other hedge funds are holding OMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Owens & Minor, Inc. (NYSE:OMI).
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.